Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00093366 · COMPLETED

Trial details

NCT number: NCT00093366
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases

Start date: 2004-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.